Publications included updated guidelines on management of axial spondyloarthritis (axSpA) by ASAS-EULAR and development of a modified Juvenile Spondyloarthritis Disease Activity Index (JSpADA). Definitions were published for MRI lesions of the spine in axSpA and active and structural sacroiliac (SI) joint lesions in juvenile spondyloarthritis (JSpA). Anatomic variants of the sacroiliac joint were commonly detected using synthetic CT derived from pelvis MRI images. Anti-CD74 antibodies hold promise as a diagnostic biomarker for axSpA; however, the mechanism of such antibody development seems unrelated to gastrointestinal inflammation. High impact clinical publications in spondyloarthritis addressed lab-based and imaging biomarkers, outcome measures, and updated management guidelines.
Keyphrases
- disease activity
- ankylosing spondylitis
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- contrast enhanced
- juvenile idiopathic arthritis
- magnetic resonance imaging
- clinical practice
- computed tomography
- oxidative stress
- high resolution
- diffusion weighted imaging
- randomized controlled trial
- deep learning
- magnetic resonance
- mass spectrometry
- photodynamic therapy
- artificial intelligence
- room temperature
- machine learning
- positron emission tomography
- genome wide